Elutia (ELUT) EV/EBIT: History & Chart

Elutia Inc(ELUT)

Biotechnology · Gaithersburg, MD

$0.82+0.04 (+5.51%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Elutia Inc

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac patch for repairs, such as atrial and ventricular septal defects and suture-line buttressing, and pledgets, as well as for pericardial closure to reconstruct the pericardium after heart surgery. In addition, the company provides Tyke, a thinner pliable matrix for the repair of pericardial structures for neonates and infants; as an epicardial for damaged or repaired cardiac structures; and as a patch material for cardiac defects, as well as VasCure, a patch material to repair or reconstruct the peripheral vasculature. The company sells its products directly to hospitals and other healthcare facilities through independent sales agents. The company was formerly known as Aziyo Biologics, Inc. and changed its name to Elutia Inc. in September 2023. Elutia Inc. was incorporated in 2015 and is headquartered in Gaithersburg, Maryland.

Gaithersburg, MD

26 employees

elutia.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: C. Randal Mills

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Elutia Inc (ELUT)	$36.32M	N/A	N/A	N/A	N/A
HeartBeam, Inc. (BEAT)vs ›	$36.31M	N/A	N/A	N/A	N/A
BriaCell Therapeutics Corp. (BCTX)vs ›	$36.37M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$36.05M	N/A	8.66x	44.05x	43.98x
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.61M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$35.89M	N/A	50.30x	467.13x	265.91x
Edesa Biotech, Inc. (EDSA)vs ›	$37.67M	N/A	N/A	N/A	N/A
Harvard Bioscience, Inc. (HBIO)vs ›	$38.34M	74.04x	60.42x	123.40x	130.57x
Grace Therapeutics, Inc. (GRCE)vs ›	$33.52M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.42M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Elutia Inc (ELUT)

$36.32M

N/A

HeartBeam, Inc. (BEAT)vs ›

$36.31M

N/A

BriaCell Therapeutics Corp. (BCTX)vs ›

$36.37M